42 C
May 19, 2024
The Hona News

Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?

The Food and Drug Administration announced last week that it’s investigating reports of secondary cancers in patients who received CAR T-cell therapy, one of a suite of immunotherapies that have revolutionized cancer care over the past decade. The treatment reprograms a patient’s T cells, a key part of the immune system, to recognize and attack cancer cells.

Source link

Related posts

Video: Can extra salt hurt your kidneys?


Global taskforce of scientists develop a unifying framework for the 'Human Affectome'


Researchers identify bacterial strain that demonstrates a potentially protective role in celiac disease


Leave a Comment